Related Experiment Videos
Ischemic preconditioning in chronically hypoxic neonatal rat heart
Ivana Ostádalová1, Bohuslav Ostádal, Daniela Jarkovská
1Institute of Physiology, Academy of Sciences of the Czech Republic, Center for Experimental Cardiovascular Research, Prague, Czech Republic. iostadal@biomed.cas.cz
Pediatric Research
|October 3, 2002
Summary
Postnatal intermittent high altitude (IHA) exposure improves heart recovery after ischemia in young rats. Combining IHA with ischemic preconditioning (IP) offers greater protection, suggesting distinct adaptive mechanisms.
Area of Science:
- Cardiovascular Physiology
- Neonatal Adaptation
- Hypoxia Research
Background:
- The developing heart's tolerance to ischemia varies with age.
- Chronic hypoxia may alter cardiac resilience.
- Ischemic preconditioning (IP) is a known cardioprotective strategy.
Purpose of the Study:
- To investigate the effects of prenatal and postnatal intermittent high altitude (IHA) exposure on cardiac ischemic tolerance in developing rats.
- To evaluate the combined effects of IHA and IP on heart recovery.
- To explore the potential involvement of mitochondrial K(ATP) channels and nitric oxide synthase (NOS) in these protective mechanisms.
Main Methods:
- Isolated rat hearts perfused in Langendorff mode at different postnatal days (1, 4, 7, 10).
- Global ischemia and reperfusion protocols to assess contractile function recovery.
- Induction of prenatal and postnatal hypoxia via simulated high altitude (IHA) and ischemic preconditioning (IP).
Main Results:
- Prenatal IHA did not improve ischemic tolerance at day 1.
- Postnatal IHA significantly improved recovery of developed force on days 7 and 10.
- Combined IHA and IP provided superior protection across all tested ages compared to either intervention alone.
Conclusions:
- Postnatal adaptation to chronic hypoxia enhances cardiac recovery from ischemia.
- Mitochondrial K(ATP) channels and nitric oxide appear involved in hypoxia-induced protection, but not IP in neonates.
- Combined IHA and IP strategies offer significant cardioprotection in developing hearts.